These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 7763050

  • 1. Modulation of O6-methylguanine-DNA methyltransferase-mediated nimustine resistance in recurrent malignant gliomas by streptozotocin--a preliminary report.
    Zhao KM, Chen JM, Zuo HZ, Wu Y, Zhang YP.
    Anticancer Res; 1995; 15(2):645-8. PubMed ID: 7763050
    [Abstract] [Full Text] [Related]

  • 2. O6-alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications.
    Hotta T, Saito Y, Fujita H, Mikami T, Kurisu K, Kiya K, Uozumi T, Isowa G, Ishizaki K, Ikenaga M.
    J Neurooncol; 1994; 21(2):135-40. PubMed ID: 7861189
    [Abstract] [Full Text] [Related]

  • 3. In situ detection of O6-methylguanine-DNA methyltransferase messenger RNA in paraffin-embedded human astrocytic tumor tissues by nested in situ RT-PCR is useful in predicting chemotherapy-resistance of tumors.
    Ohe N, Saio M, Kijima M, Tamakawa N, Suwa T, Kojima Y, Yano H, Kaku Y, Iwama T, Shinoda J, Sakai N, Takami T.
    Int J Oncol; 2003 Mar; 22(3):543-9. PubMed ID: 12579307
    [Abstract] [Full Text] [Related]

  • 4. Expression of O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea resistance of human brain tumors.
    Nagane M, Asai A, Shibui S, Nomura K, Matsutani M, Kuchino Y.
    Jpn J Clin Oncol; 1992 Jun; 22(3):143-9. PubMed ID: 1518162
    [Abstract] [Full Text] [Related]

  • 5. [Possible role of 06-methylguanine-DNA-transferase in the response of patients with primary tumor of the brain to chemotherapy using chloro-ethyl-nitroso-urea: results of a current study].
    Arena G, Abbondandolo A, Rossi O, Gentile SL, Bruzzone E, Francaviglia N, Capellini C.
    Boll Soc Ital Biol Sper; 1990 May; 66(5):495-8. PubMed ID: 2168722
    [Abstract] [Full Text] [Related]

  • 6. [Circumvention of ACNU-resistance in rat glioma cells by pretreatment with O6-methylguanine].
    Mineura K, Fushimi S, Sasaki J, Sasajima H, Ishino Y, Kowada M.
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):259-62. PubMed ID: 2919893
    [Abstract] [Full Text] [Related]

  • 7. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
    Pollack IF, Hamilton RL, Sobol RW, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL.
    J Clin Oncol; 2006 Jul 20; 24(21):3431-7. PubMed ID: 16849758
    [Abstract] [Full Text] [Related]

  • 8. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P, Coulibaly B, Nanni I, Fina F, Eudes N, Giorgi R, Barrie M, Chinot O, Fuentes S, Dufour H, Ouafik L, Figarella-Branger D.
    Cancer; 2009 Oct 15; 115(20):4783-94. PubMed ID: 19637364
    [Abstract] [Full Text] [Related]

  • 9. [Resent advances in chemotherapy for malignant brain tumors].
    Shibui S.
    Gan To Kagaku Ryoho; 2005 Apr 15; 32(4):442-7. PubMed ID: 15853207
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
    Tanaka S, Kobayashi I, Utsuki S, Oka H, Yasui Y, Fujii K.
    Oncol Rep; 2005 Nov 15; 14(5):1275-80. PubMed ID: 16211296
    [Abstract] [Full Text] [Related]

  • 11. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.
    Dazzi C, Cariello A, Giannini M, Del Duca M, Giovanis P, Fiorentini G, Leoni M, Rosti G, Turci D, Tienghi A, Vertogen B, Zumaglini F, De Giorgi U, Marangolo M.
    Anticancer Res; 2000 Nov 15; 20(1B):515-8. PubMed ID: 10769716
    [Abstract] [Full Text] [Related]

  • 12. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE, Tsujii H, Hasegawa A, Yanagi T, Takagi R, Kamada T, Tsuji H, Takakura K, Organizing Committee of the Central Nervous System Tumor Working Group.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):390-6. PubMed ID: 17459607
    [Abstract] [Full Text] [Related]

  • 13. [Radiotherapy of astrocytoma].
    Koga K, Nishikawa K, Watanabe K, Wakisaka S.
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct 20; 23(10):2546-50. PubMed ID: 2850329
    [No Abstract] [Full Text] [Related]

  • 14. [Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases].
    Zhang JP, Shi HL, Sai K, Yue WY, Mu YG, Zhang XH, Chen ZP.
    Ai Zheng; 2006 Dec 20; 25(12):1533-7. PubMed ID: 17166381
    [Abstract] [Full Text] [Related]

  • 15. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
    Kokkinakis DM, Ahmed MM, Delgado R, Fruitwala MM, Mohiuddin M, Albores-Saavedra J.
    Cancer Res; 1997 Dec 01; 57(23):5360-8. PubMed ID: 9393761
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic results of intra-arterial chemotherapy in patients with malignant glioma.
    Hirano Y, Mineura K, Mizoi K, Tomura N.
    Int J Oncol; 1998 Sep 01; 13(3):537-42. PubMed ID: 9683790
    [Abstract] [Full Text] [Related]

  • 17. Pre-irradiation chemotherapy for newly diagnosed high grade astrocytoma.
    Mathieu NT, Genet D, Labrousse F, Bouillet P, Denes SL, Martin J, Labourey JL, Venat L, Clavere P, Moreau JJ.
    Anticancer Res; 2004 Sep 01; 24(2C):1249-53. PubMed ID: 15154655
    [Abstract] [Full Text] [Related]

  • 18. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.
    Silber JR, Blank A, Bobola MS, Ghatan S, Kolstoe DD, Berger MS.
    Clin Cancer Res; 1999 Apr 01; 5(4):807-14. PubMed ID: 10213216
    [Abstract] [Full Text] [Related]

  • 19. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M.
    BMC Cancer; 2006 Oct 18; 6():247. PubMed ID: 17049083
    [Abstract] [Full Text] [Related]

  • 20. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M, Müller B, Koch R, Bamberg M, Krauseneck P, Neuro-Oncology Working Group of the German Cancer Society.
    J Clin Oncol; 2003 Sep 01; 21(17):3276-84. PubMed ID: 12947063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.